Search

everythinglearnresearchcommunity

for

Search:↓

Pregnant women with isolated hypothyroxinemia face more health issues, so iodine and folic acid supplements are important before and during early pregnancy.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.

PCOS phenotypes A and B are more common and linked to higher health risks in women from the Ecuadorian Andes.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The model and estimator can predict drug exposure in kidney transplant patients well.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Estrogens and progesterone are key in regulating melasma pigmentation.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Tofacitinib is an effective and safe treatment for alopecia areata.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.